About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

Insights

Company News Events Insights Webinars Virtual Tours

Q&A: How a highly clinically translatable NASH model helps new drug discovery

Complimentary Download: A New Obesogenic NASH/MASH Mouse Model. How a highly clinically translatable NASH model helps new drug discovery | BioDuro-Sundia
March 15, 2024

IDD Explained: An Interview with BioDuro-Sundia’s Head of Integrated Drug Discovery Services, Dr. Frank Ruebsam

IDD Explained: An Interview with BioDuro-Sundia’s Head of Integrated Drug Discovery Services, Dr. Frank Ruebsam | BioDuro-Sundia | Moving You Forward
November 10, 2023

Q&A: Building new models for preclinical in vivo immuno-oncology efficacy studies

BioDuro-Sundia enhances oncology services with advanced in vivo immuno-oncology models, addressing crucial phases of drug development like pharmacodynamics
July 25, 2023

Q&A: Process chemistry for IND filing support

BioDuro-Sundia's process chemistry services ensure balanced, efficient, and cost-effective CMC solutions for IND filing, backed by two decades of expertise
May 06, 2023

FAQ: Controlled release

​Controlled release is a drug delivery mechanism that allows for the gradual release of a drug into the body over a specific period of time.
March 11, 2023

Solution Engine 2.0

Solution Engine 2.0 saves time and money by screening amorphous solid dispersion and controlled release technologies with minimal API addressing issues early
March 11, 2023

Strategic control of genotoxic impurity in innovative drug development

BioDuro-Sundia is proud to highlight Dr. Jingli Wang’s insights on the topic of strategic controls on genotoxic impurities in process development and ...
March 11, 2023

Benefits of using a CRDMO

CRDMOs are staffed by trained professionals who are experienced in working with clinical research data.
March 11, 2023
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all